| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |